Previous studies provided evidence that treatments with sEH inhibitors could reduce the infarct size and chronic cardiac remodeling post MI, which was beneficial in preventing electrical remodeling and cardiac arrhythmias post MI, as well as reducing inflammation (Li et al., 2009). This evidence concerns the gene EPHX2 and myocardial infarction.